AAAAAA
Results:
1-18
|
Results: 18
Authors:
ETON O
KHARKEVITCH DD
GIANAN MA
ROSS MI
ITOH K
PRIDE MW
DONAWHO C
BUZAID AC
MANSFIELD PF
LEE JE
LEGHA SS
PLAGER C
PAPADOPOULOS NE
BEDIKIAN AY
BENJAMIN RS
BALCH CM
Citation: O. Eton et al., ACTIVE IMMUNOTHERAPY WITH ULTRAVIOLET B-IRRADIATED AUTOLOGOUS WHOLE MELANOMA-CELLS PLUS DETOX IN PATIENTS WITH METASTATIC MELANOMA, Clinical cancer research, 4(3), 1998, pp. 619-627
Authors:
ETON O
KHARKEVITCH DD
GIANAN MA
ROSS MI
ITOH K
PRIDE MW
DONAWHO C
BUZAID AC
MANSFIELD PF
LEE JE
LEGHA SS
PLAGER C
PAPADOPOULOS NE
BEDIKIAN AY
BENJAMIN RS
BALCH CM
Citation: O. Eton et al., ACTIVE IMMUNOTHERAPY WITH ULTRAVIOLET B-IRRADIATED AUTOLOGOUS WHOLE MELANOMA-CELLS PLUS DETOX IN PATIENTS WITH METASTATIC MELANOMA, Clinical cancer research, 4(3), 1998, pp. 619-627
Authors:
PRIDE MW
SHUEY S
GRILLOLOPEZ A
BRASLAWSKY O
ROSS M
LEGHA SS
ETON O
BUZAID A
IOANNIDES C
MURRAY JL
Citation: Mw. Pride et al., ENHANCEMENT OF CELL-MEDIATED-IMMUNITY IN MELANOMA PATIENTS IMMUNIZED WITH MURINE ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES (MELIMMUNE(R)) THAT MIMIC THE HIGH-MOLECULAR-WEIGHT PROTEOGLYCAN ANTIGEN, Clinical cancer research, 4(10), 1998, pp. 2363-2370
Authors:
BUZAID AC
ALIOSMAN F
AKANDE N
GRIMM EA
LEE JJ
BEDIKIAN A
ETON O
PAPADOPOULOS N
PLAGER C
LEGHA SS
BENJAMIN RS
Citation: Ac. Buzaid et al., DNA-DAMAGE IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS CORRELATES WITH RESPONSE TO BIOCHEMOTHERAPY IN MELANOMA, Melanoma research, 8(2), 1998, pp. 145-148
Authors:
ANDERSON CM
BUZAID AC
SUSSMAN J
LEE JJ
ALIOSMAN F
BRAUNSCHWEIGER PG
PLAGER C
BEDIKIAN A
PAPADOPOULOS N
ETON O
LEGHA SS
GRIMM EA
Citation: Cm. Anderson et al., NITRIC-OXIDE AND NEOPTERIN LEVELS AND CLINICAL-RESPONSE IN STAGE-III MELANOMA PATIENTS RECEIVING CONCURRENT BIOCHEMOTHERAPY, Melanoma research, 8(2), 1998, pp. 149-155
Authors:
LEGHA SS
RING S
ETON O
BEDIKIAN A
BUZAID AC
PLAGER C
PAPADOPOULOS N
Citation: Ss. Legha et al., DEVELOPMENT OF A BIOCHEMOTHERAPY REGIMEN WITH CONCURRENT ADMINISTRATION OF CISPLATIN, VINBLASTINE, DACARBAZINE, INTERFERON-ALPHA, AND INTERLEUKIN-2 FOR PATIENTS WITH METASTATIC MELANOMA, Journal of clinical oncology, 16(5), 1998, pp. 1752-1759
Authors:
ETON O
LEGHA SS
MOON TE
BUZAID AC
PAPADOPOULOS NE
PLAGER C
BURGESS AM
BEDIKIAN AY
RING S
DONG Q
GLASSMAN AB
BALCH CM
BENJAMIN RS
Citation: O. Eton et al., PROGNOSTIC FACTORS FOR SURVIVAL OF PATIENTS TREATED SYSTEMICALLY FOR DISSEMINATED MELANOMA, Journal of clinical oncology, 16(3), 1998, pp. 1103-1111
Authors:
YEUNG SCJ
ETON O
BURTON DW
DEFTOS LJ
VASSILOPOULOUSELLIN R
GAGEL RF
Citation: Scj. Yeung et al., HYPERCALCEMIA DUE TO PARATHYROID HORMONE-RELATED PROTEIN SECRETION BYMELANOMA, Hormone research, 49(6), 1998, pp. 288-291
Authors:
LEGHA SS
RING S
ETON O
BEDIKIAN A
PLAGER C
PAPADOPOULOS N
Citation: Ss. Legha et al., DEVELOPMENT AND RESULTS OF BIOCHEMOTHERAPY IN METASTATIC MELANOMA - THE UNIVERSITY-OF-TEXAS-M.D.-ANDERSON-CANCER-CENTER EXPERIENCE, The cancer journal from Scientific American, 3, 1997, pp. 9-15
Authors:
BEDIKIAN AY
LEGHA SS
ETON O
BUZAID AC
PAPADOPOULOS N
COATES S
SIMMONS T
NEEFE J
VONROEMELING R
Citation: Ay. Bedikian et al., PHASE-II TRIAL OF TIRAPAZAMINE COMBINED WITH CISPLATIN IN CHEMOTHERAPY OF ADVANCED MALIGNANT-MELANOMA, Annals of oncology, 8(4), 1997, pp. 363-367
Authors:
BUZAID AC
ROSS MI
BALCH CM
SOONG SJ
MCCARTHY WH
TINOCO L
MANSFIELD P
LEE JE
BEDIKIAN A
ETON O
PLAGER C
PAPADOPOULOS N
LEGHA SS
BENJAMIN RS
Citation: Ac. Buzaid et al., CRITICAL ANALYSIS OF THE CURRENT AMERICAN JOINT COMMITTEE ON CANCER STAGING SYSTEM FOR CUTANEOUS MELANOMA AND PROPOSAL OF A NEW STAGING SYSTEM, Journal of clinical oncology, 15(3), 1997, pp. 1039-1051
Authors:
MURRAY JL
KLEINERMAN ES
JIA SF
ROSENBLUM MG
ETON O
BUZAID A
LEGHA S
ROSS MI
THOMPSON L
MUJOO K
RIEGER PT
SALEH M
KHAZAELI MB
VADHANRAJ S
Citation: Jl. Murray et al., PHASE-IA IB TRIAL OF ANTI-GD2 CHIMERIC MONOCLONAL-ANTIBODY-14.18 (CH14.18) AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN METASTATIC MELANOMA/, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 206-217
Authors:
LEGHA SS
RING S
BEDIKIAN A
PLAGER C
ETON O
BUZAID AC
PAPADOPOULOS N
Citation: Ss. Legha et al., TREATMENT OF METASTATIC MELANOMA WITH COMBINED CHEMOTHERAPY CONTAINING CISPLATIN, VINBLASTINE AND DACARBAZINE (CVD) AND BIOTHERAPY USING INTERLEUKIN-2 AND INTERFERON-ALPHA, Annals of oncology, 7(8), 1996, pp. 827-835
Authors:
ETON O
TALPAZ M
LEE KH
ROTHBERG JM
BRELL JM
BENJAMIN RS
Citation: O. Eton et al., PHASE-II TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-2 AND INTERFERON-ALPHA-2A - IMPLICATIONS FOR THE TREATMENT OF PATIENTS WITH METASTATIC MELANOMA, Cancer, 77(5), 1996, pp. 893-899
Authors:
TYLER DS
FRANCIS GM
FREDERICK M
TRAN AH
ORDONEZ NG
SMITH JL
ETON O
ROSS M
GRIMM EA
Citation: Ds. Tyler et al., INTERLEUKIN-1 PRODUCTION IN TUMOR-CELLS OF HUMAN-MELANOMA SURGICAL SPECIMENS, Journal of interferon & cytokine research, 15(4), 1995, pp. 331-340
Authors:
BEDIKIAN AY
WEISS GR
LEGHA SS
BURRIS HA
ECKARDT JR
JENKINS J
ETON O
BUZAID AC
SMETZER L
VONHOFF DD
BENJAMIN RS
Citation: Ay. Bedikian et al., PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH ADVANCED CUTANEOUS MALIGNANT-MELANOMA PREVIOUSLY UNTREATED WITH CHEMOTHERAPY, Journal of clinical oncology, 13(12), 1995, pp. 2895-2899
Authors:
BUZAID AC
GRIMM EA
ALIOSMAN F
RING S
ETON O
PAPADOPOULOS NE
BEDIKIAN A
PLAGER C
LEGHA SS
BENJAMIN R
Citation: Ac. Buzaid et al., MECHANISM OF THE ANTITUMOR EFFECT OF BIOCHEMOTHERAPY IN MELANOMA - PRELIMINARY-RESULTS, Melanoma research, 4(5), 1994, pp. 327-330
Authors:
UMEZU Y
AUGUSTUS LB
SEITO D
HAYAKAWA K
ROSS MI
ETON O
SWANSON DA
ITOH K
Citation: Y. Umezu et al., INCREASE IN THE ABILITY OF HUMAN CANCER-CELLS TO INDUCE CYTOTOXIC T-LYMPHOCYTES BY ULTRAVIOLET-IRRADIATION, Cancer immunology and immunotherapy, 37(6), 1993, pp. 392-399
Risultati:
1-18
|